MDS buys U.S.-based Molecular Devices in bid for more customers, products (CP via Yahoo! Canada News)
TORONTO (CP) - MDS Inc. (TSX:MDS) is acquiring Molecular Devices Corp., a California-based bio-analytical measurement systems maker, in a US$615-million cash deal that will enable the Canadian life sciences company to reach more customers and offer a wider array of products.

Schering-Plough hits earnings goal (CNN Money)
Cholesterol drugs Vytorin and Zetia and arthritis remedy Remicade push profits up sharply, meeting expectations.

Panel Recommends That FDA Not Create Specific Effectiveness Standard For Oral Contraceptive Approvals (Medical News Today)
A panel of gynecologists, researchers and other medical experts on Wednesday at the end of a two-day meeting convened by FDA recommended the agency not set a specific standard of effectiveness for approval of oral contraceptives, the AP/Minneapolis Star Tribune reports (Bridges, AP/Minneapolis Star Tribune, 1/25). [click link for full article]